|
Issue |
Title |
|
No 9 (2013) |
Angiotensin converting enzyme inhibitors in treatment practice: similarity and difference. How to make the right choice |
Abstract
PDF (Rus)
|
O. D. Ostroumova, G. N. Schukina, V. M. Fomina |
|
No 9 (2013) |
Chronic thromboembolic pulmonary hypertension: approaches to diagnosis and treatment |
Abstract
PDF (Rus)
|
N. A. Shostak, A. A. Klimenko, N. A. Demidova, S. M. Sorokoletov, K. V. Razumov, N. M. Babadaeva |
|
No 9 (2013) |
Conservative drug therapy for drug-resistant hypertension: time for compromise |
Abstract
PDF (Rus)
|
A. O. Konradi |
|
No 9 (2013) |
Aortic pressure: current views on clinical and prognostic value of measure |
Abstract
PDF (Rus)
|
Yu. V. Kotovskaya, Gh. D. Kobalava |
|
No 9 (2013) |
Angiotensin II receptor blockers and cardiorenal risk management: Irbesartan status |
Abstract
PDF (Rus)
|
V. V. Fomin |
|
No 9 (2013) |
Treatment and secondary prevention of myocardial infarction |
Abstract
PDF (Rus)
|
E. V. Kuleshova, A. V. Panov |
|
1 - 6 of 6 Items |
|